Transfection Technologies Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Transfection Technologies Market By Product Type (Reagent, Instrument, and Others), Transfection Method (Reagent-Based Method, Lipofection, Calcium phosphate, DEAE-dextran, Cationic polymers, Activated dendrimers, and Magnetic Beads), and Instrument-Based Method (Electroporation, Microinjection, Laserfection, and Biolistic technology)), Application (Therapeutic Delivery, Bio-Medical Research, Protein Production, and Others), End User (Research Centers and Academic Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Transfection Technologies Market Size is around USD 1023.8 million in 2022 and is poised to grow at a significant CAGR of 8.9% over 2022–2028. Transfection is the process of introducing nucleic acids into eukaryotic cells by chemical or physical methods. It helps in the study of gene function and protein expression in a cellular environment. The main purpose of transfection is to study the function of genes or gene products, by enhancing or inhibiting specific gene expression in cells, and to produce recombinant proteins in mammalian cells. There are various transfection methods are there like lipofection, electroporation, nucleofection, co-transfection, cationic lipid transfection, and in-vivo transfection. Advances in cell research technologies and therapeutic deliveries, and a rise in funding for research and development in transfection technology by government and private firms are boosting the global transfection technologies market growth. Also, the prevalence of cancer, obesity, and various chronic lifestyle diseases is rising the demand for transfection technology due to research in cell-based therapies. Reagent-based transfection technology is expected to grow at a higher pace and will dominate the market due to its cost-effectiveness and less complicated methods. However, instrument-based methods, such as biolistic technology, and microinjection are also driving the global transfection market growth. The key global players like Bio-RAD Laboratories, Lonza Group AG, Maxcyte, Mirus Bio, Polyplus Transfection, Promega Corporation, and Thermo Fisher Scientific are influencing the infection technologies market growth through new innovation and investment in the research and development sector. The transfection technologies market is segmented into North America, Europe, Latin America, Asia Specific, and the Middle East and Africa. North America holds the major transfection technologies market share due to an increase in the cases of infectious diseases.

Recent Market Developments:

In Aug 2022, Synthego launched engineered cell libraries to validate targets with speed and accelerate drug discovery.

In Aug 2021, Polyplus launched a new transfection reagent for large-scale viral vector production.

Transfection Technologies Market

MARKET SUMMARY
-
8.9%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 8.9%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North America

Transfection Technologies Market

  • The global transfection technologies market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global transfection technologies market gives historical, current, and future market sizes on the basis of product type, transfection method, application, end-user, and geography.
Key Players
  • Polyplus Transfection
  • Promega Corporation
  • Thermo Fisher Scientific
  • Sigma Aldrich
  • Synthego
Transfection Technologies Market Dynamics

The prevalence of various cancers, chronic diseases, and viral infections are the key reason for the transfection market growth around the globe. The rise of these diseases occurs due to declining immunities, and harsh lifestyles. According to WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The most common in 2020 were breast (2.26 million cases), and lung (2.21 million cases) cancers. According to CDC, 51.8% of US adults had at least 1 chronic condition, and 27.2% had multiple chronic conditions. Prevalence was highest among women, non-Hispanic white adults, adults aged 65 or older, and those living in rural areas. These trends depict that the global transfection technologies market will grow further in the forecasted years.


North-America Got Significant Share

Transfection Technologies Market

On the basis of regions, the market share is divided into North America, Asia-pacific, Europe, and the Middle East, and the African region. North America dominates the transfection technologies market due to an increase in the cases of infectious diseases, and a rise in the use of cell-based products which require transfection methods to treat chronic diseases such as cancer, obesity tuberculosis, chronic diseases, and cardiovascular diseases in this region. The transfection technologies market in the Asia Pacific is likely to hold a significant revenue share in 2021, and, in the following years, it is predicted to increase rapidly due to the rise in the prevalence of cancer and chronic diseases in this region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The transfection technologies market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario.
Transfection Technologies Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The transfection technologies market is projected to expand at a CAGR of 8.9% during the forecast period

Bio-RAD Laboratories, Lonza Group AG, Maxcyte, Mirus Bio, Polyplus Transfection, Promega Corporation

North America is the fastest-growing region for transfection technologies market


Report

Table Of Content

1. Executive Summary
2. Global Transfection Technologies Market Introduction
2.1. Global Transfection Technologies Market – Taxonomy
2.2. Global Transfection Technologies Market –Definitions
2.2.1. By Product Type
2.2.2. By Transfection Method
2.2.3. By Application
2.2.4. By End User
2.2.5. By Region
3. Global Transfection Technologies Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Transfection Technologies Market Dynamic Factors – Impact Analysis
3.6. Global Transfection Technologies Market – Competition Landscape
3.7. Epidemiology
4. Global Transfection Technologies Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Transfection Technologies Market, By Product Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Reagents
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Others
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Transfection Technologies Market, By Transfection Method, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Reagent-Based Method
6.1.1. Lipofection
6.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.1.3. Market Opportunity Analysis
6.1.2. Calcium phosphate
6.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.2.3. Market Opportunity Analysis
6.1.3. DEAE-dextran
6.1.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3.3. Market Opportunity Analysis
6.1.4. Cationic polymers
6.1.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.4.3. Market Opportunity Analysis
6.1.5. Activated dendrimers
6.1.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.5.3. Market Opportunity Analysis
6.1.6. Magnetic Beads
6.1.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.6.3. Market Opportunity Analysis
6.2. Instrument-Based Method
6.2.1. Electroporation
6.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.1.3. Market Opportunity Analysis
6.2.2. Microinjection
6.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.2.3. Market Opportunity Analysis
6.2.3. Laserfection
6.2.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3.3. Market Opportunity Analysis
6.2.4. Biolistic technology
6.2.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.4.3. Market Opportunity Analysis
7. Global Transfection Technologies Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Therapeutic Delivery
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Bio-Medical Research
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Protein Production
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Transfection Technologies Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Research Centers and Academic Institutes
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospitals and Clinics
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Pharmaceutical and Biotechnology Companies
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Transfection Technologies Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Transfection Technologies Market – Opportunity Analysis Index, By Product Type, By Transfection Method, By Application, By End User, and Region, 2022-2028
10. North America Transfection Technologies Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Reagents
10.1.2. Instruments
10.1.3. Others
10.2. Transfection Method Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Reagent-Based Method
10.2.1.1. Lipofection
10.2.1.2. Calcium phosphate
10.2.1.3. DEAE-dextran
10.2.1.4. Cationic polymers
10.2.1.5. Activated dendrimers
10.2.1.6. Magnetic Beads
10.2.2. Instrument-Based Method
10.2.2.1. Electroporation
10.2.2.2. Microinjection
10.2.2.3. Laserfection
10.2.2.4. Biolistic technology
10.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Therapeutic Delivery
10.3.2. Bio-Medical Research
10.3.3. Protein Production
10.3.4. Others
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Research Centers and Academic Institutes
10.4.2. Hospitals and Clinics
10.4.3. Pharmaceutical and Biotechnology Companies
10.4.4. Others
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Transfection Technologies Market – Opportunity Analysis Index, By Product Type, By Transfection Method, By Application, By End User, and Country, 2022-2028
10.7. North America Transfection Technologies Market Dynamics – Trends
11. Europe Transfection Technologies Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Reagents
11.1.2. Instruments
11.1.3. Others
11.2. Transfection Method Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Reagent-Based Method
11.2.1.1. Lipofection
11.2.1.2. Calcium phosphate
11.2.1.3. DEAE-dextran
11.2.1.4. Cationic polymers
11.2.1.5. Activated dendrimers
11.2.1.6. Magnetic Beads
11.2.2. Instrument-Based Method
11.2.2.1. Electroporation
11.2.2.2. Microinjection
11.2.2.3. Laserfection
11.2.2.4. Biolistic technology
11.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Therapeutic Delivery
11.3.2. Bio-Medical Research
11.3.3. Protein Production
11.3.4. Others
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Research Centers and Academic Institutes
11.4.2. Hospitals and Clinics
11.4.3. Pharmaceutical and Biotechnology Companies
11.4.4. Others
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Transfection Technologies Market – Opportunity Analysis Index, By Product Type, By Transfection Method, By Application, By End User, and Country, 2022-2028
11.7. Europe Transfection Technologies Market Dynamics – Trends
12. Asia-Pacific Transfection Technologies Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Reagents
12.1.2. Instruments
12.1.3. Others
12.2. Transfection Method Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Reagent-Based Method
12.2.1.1. Lipofection
12.2.1.2. Calcium phosphate
12.2.1.3. DEAE-dextran
12.2.1.4. Cationic polymers
12.2.1.5. Activated dendrimers
12.2.1.6. Magnetic Beads
12.2.2. Instrument-Based Method
12.2.2.1. Electroporation
12.2.2.2. Microinjection
12.2.2.3. Laserfection
12.2.2.4. Biolistic technology
12.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Therapeutic Delivery
12.3.2. Bio-Medical Research
12.3.3. Protein Production
12.3.4. Others
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Research Centers and Academic Institutes
12.4.2. Hospitals and Clinics
12.4.3. Pharmaceutical and Biotechnology Companies
12.4.4. Others
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Transfection Technologies Market – Opportunity Analysis Index, By Product Type, By Transfection Method, By Application, By End User, and Country, 2022-2028
12.7. Asia-Pacific Transfection Technologies Market Dynamics – Trends
13. Latin America Transfection Technologies Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Reagents
13.1.2. Instruments
13.1.3. Others
13.2. Transfection Method Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Reagent-Based Method
13.2.1.1. Lipofection
13.2.1.2. Calcium phosphate
13.2.1.3. DEAE-dextran
13.2.1.4. Cationic polymers
13.2.1.5. Activated dendrimers
13.2.1.6. Magnetic Beads
13.2.2. Instrument-Based Method
13.2.2.1. Electroporation
13.2.2.2. Microinjection
13.2.2.3. Laserfection
13.2.2.4. Biolistic technology
13.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Therapeutic Delivery
13.3.2. Bio-Medical Research
13.3.3. Protein Production
13.3.4. Others
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Research Centers and Academic Institutes
13.4.2. Hospitals and Clinics
13.4.3. Pharmaceutical and Biotechnology Companies
13.4.4. Others
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Transfection Technologies Market – Opportunity Analysis Index, By Product Type, By Transfection Method, By Application, By End User, and Country, 2022-2028
13.7. Latin America Transfection Technologies Market Dynamics – Trends
14. Middle East and Africa Transfection Technologies Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Reagents
14.1.2. Instruments
14.1.3. Others
14.2. Transfection Method Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Reagent-Based Method
14.2.1.1. Lipofection
14.2.1.2. Calcium phosphate
14.2.1.3. DEAE-dextran
14.2.1.4. Cationic polymers
14.2.1.5. Activated dendrimers
14.2.1.6. Magnetic Beads
14.2.2. Instrument-Based Method
14.2.2.1. Electroporation
14.2.2.2. Microinjection
14.2.2.3. Laserfection
14.2.2.4. Biolistic technology
14.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Therapeutic Delivery
14.3.2. Bio-Medical Research
14.3.3. Protein Production
14.3.4. Others
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Research Centers and Academic Institutes
14.4.2. Hospitals and Clinics
14.4.3. Pharmaceutical and Biotechnology Companies
14.4.4. Others
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Transfection Technologies Market – Opportunity Analysis Index, By Product Type, By Transfection Method, By Application, By End User, and Country, 2022-2028
14.7. MEA Transfection Technologies Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Product Types, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Bio-RAD Laboratories
15.2.2. Lonza Group AG
15.2.3. Maxcyte
15.2.4. Mirus Bio
15.2.5. Polyplus Transfection
15.2.6. Promega Corporation
15.2.7. Thermo Fisher Scientific
15.2.8. Roche
15.2.9. Sigma Aldrich
15.2.10. Synthego
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Bio-RAD Laboratories
  • Lonza Group AG
  • Maxcyte
  • Mirus Bio
  • Polyplus Transfection
  • Promega Corporation
  • Thermo Fisher Scientific
  • Roche
  • Sigma Aldrich
  • Synthego

Description

Transfection Technologies Market Size is around USD 1023.8 million in 2022 and is poised to grow at a significant CAGR of 8.9% over 2022–2028. Transfection is the process of introducing nucleic acids into eukaryotic cells by chemical or physical methods. It helps in the study of gene function and protein expression in a cellular environment. The main purpose of transfection is to study the function of genes or gene products, by enhancing or inhibiting specific gene expression in cells, and to produce recombinant proteins in mammalian cells. There are various transfection methods are there like lipofection, electroporation, nucleofection, co-transfection, cationic lipid transfection, and in-vivo transfection. Advances in cell research technologies and therapeutic deliveries, and a rise in funding for research and development in transfection technology by government and private firms are boosting the global transfection technologies market growth. Also, the prevalence of cancer, obesity, and various chronic lifestyle diseases is rising the demand for transfection technology due to research in cell-based therapies. Reagent-based transfection technology is expected to grow at a higher pace and will dominate the market due to its cost-effectiveness and less complicated methods. However, instrument-based methods, such as biolistic technology, and microinjection are also driving the global transfection market growth. The key global players like Bio-RAD Laboratories, Lonza Group AG, Maxcyte, Mirus Bio, Polyplus Transfection, Promega Corporation, and Thermo Fisher Scientific are influencing the infection technologies market growth through new innovation and investment in the research and development sector. The transfection technologies market is segmented into North America, Europe, Latin America, Asia Specific, and the Middle East and Africa. North America holds the major transfection technologies market share due to an increase in the cases of infectious diseases.

Recent Market Developments:

In Aug 2022, Synthego launched engineered cell libraries to validate targets with speed and accelerate drug discovery.

In Aug 2021, Polyplus launched a new transfection reagent for large-scale viral vector production.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX